MarketFriction

Clinitech Laboratory Ltd

BSE 544220 · Healthcare Service Provider
₹33.65 -4.13%
BSE close2026-10-01
Market cap₹8.01 Cr.
P/E19.1

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales3.063.344.084.165.084.39
Expenses2.782.613.523.884.543.94
Operating Profit0.280.730.560.280.540.45
OPM %9.15%21.86%13.73%6.73%10.63%10.25%
Other Income0.020.010.050.170.110.08
Interest0.040.060.040.020.050.02
Depreciation0.190.250.310.140.250.26
Profit before tax0.070.430.260.290.350.25
Tax %14.29%30.23%15.38%41.38%14.29%52.00%
Net Profit0.070.300.220.170.300.12
EPS in Rs0.471.790.960.741.310.53
Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales4.556.386.356.408.239.48
Expenses3.725.314.995.417.408.49
Operating Profit0.831.071.360.990.830.99
OPM %18.24%16.77%21.42%15.47%10.09%10.44%
Other Income0.040.070.020.040.230.19
Interest0.080.060.070.090.060.07
Depreciation0.250.380.450.440.450.51
Profit before tax0.540.700.860.500.550.60
Tax %25.93%27.14%29.07%26.00%29.09%30.00%
Net Profit0.400.510.610.370.390.42
EPS in Rs6.003.404.072.201.711.84
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%16%14%15%
Compounded Profit Growth%3%-12%40%
Stock Price CAGR%%%-24%
Return on Equity%10%6%5%
Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital0.671.501.501.682.282.28
Reserves0.720.350.881.876.556.97
Borrowings0.540.891.030.870.000.36
Other Liabilities0.800.942.621.192.011.30
Total Liabilities2.733.686.035.6110.8410.91
Fixed Assets0.841.651.331.712.122.18
CWIP0.080.410.560.941.010.99
Investments0.090.142.020.070.070.08
Other Assets1.721.482.122.897.647.66
Total Assets2.733.686.035.6110.8410.91
Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity0.380.961.25-1.28-0.88-0.90
Cash from Investing Activity0.54-1.47-0.650.75-0.73-0.44
Cash from Financing Activity-0.880.290.090.453.980.33
Net Cash Flow0.04-0.220.68-0.082.37-1.01
Free Cash Flow0.19-0.550.97-2.49-1.73-1.45
CFO/OP64%109%114%-115%-87%-70%
Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days44.9220.6028.1734.2268.3071.23
Inventory Days32.2140.2843.6892.91
Days Payable164.61130.90124.79116.14
Cash Conversion Cycle-87.48-70.03-52.9510.9968.3071.23
Working Capital Days43.32-4.58-33.3421.67114.42163.63
ROCE %32.55%30.24%14.81%8.15%7.27%
Sep 2024Mar 2025Sep 2025Mar 2026
Promoters61.58%61.58%62.42%64.21%
FIIs0.32%0.32%0.32%0.32%
Public38.11%38.11%37.27%35.49%
No. of Shareholders346303303297

Fundamentals

Market Cap₹ 8.01 Cr.
Current Price₹ 35.1
Stock P/E19.1
Book Value₹ 40.5
ROCE7.27 %
ROE4.65 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)15%
Compounded Profit Growth (TTM)40%
Standalone figures.
Valuation
Market capRs 5 Cr
Enterprise valueRs 6 Cr
P/E (TTM)9.90x
Price to book2.73x
Price to sales0.79x
EV / EBITDA5.12x
EV / EBIT7.68x
EV / sales0.92x
Price to cash flow5.26x
Earnings yield10.10%
Profitability
Operating margin (excl. other income)16.77%
Operating margin (incl. other income)17.87%
EBITDA margin17.87%
Pre-tax margin10.97%
Net profit margin7.99%
ROE31.48%
ROCE32.55%
ROA15.91%
ROIC (approx.)20.97%
Tax rate27.14%
Other income / net worth3.78%
Growth
Sales growth (latest year)40.22%
Profit growth (latest year)27.50%
Per share
EPS (TTM)Rs 3.40
EPS (latest year)Rs 3.40
Book value per shareRs 12.33
Sales per shareRs 42.53
Cash flow per shareRs 6.40
Free cash flow per shareRs -9.67
Efficiency
Asset turnover1.73x
Fixed asset turnover3.87x
Inventory turnover11.94x
Inventory days31 days
Debtor days21 days
Debtors turnover17.72x
Creditor days116 days
Cash conversion cycle71 days
Working capital days164 days
Leverage
Total debtRs 1 Cr
Cash and bankRs 0 Cr
Net debtRs 1 Cr
Debt to equity0.48x
Net debt / EBITDA0.69x
Interest coverage12.67x
Owners' fund to total sources50.27%
Debt to assets24.18%
Cash flow
Cash from Operating Activity (latest year)Rs 1 Cr
Cash from Investing Activity (latest year)Rs -1 Cr
Cash from Financing Activity (latest year)Rs 0 Cr
Net Cash Flow (latest year)Rs -0 Cr
Free cash flow (latest year)Rs -1 Cr
FCFE (approx.: FCF + change in debt)Rs -1 Cr
Cash from ops / profit, 5 years-0.37x
Sales to cash flow6.65x
Statement figures
Net sales (TTM)Rs 6 Cr
Net sales (latest year)Rs 6 Cr
Operating profit excl. other income (latest year)Rs 1 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 1 Cr
PBDT (TTM)Rs 1 Cr
Profit before tax (TTM)Rs 1 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 1 Cr
Net profit (latest year)Rs 1 Cr
Depreciation (TTM)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 2 Cr
Total expenditure (latest year)Rs 5 Cr
Total income (latest year)Rs 6 Cr
Share capitalRs 2 Cr
ReservesRs 0 Cr
Shareholders' fundsRs 2 Cr
Total assetsRs 4 Cr
Net blockRs 2 Cr
Capital work in progressRs 0 Cr
InvestmentsRs 0 Cr
ReceivablesRs 0 Cr
InventoryRs 0 Cr
Other liabilitiesRs 1 Cr
Shares outstanding (crore)0.15
Ownership
Promoter holding64.21%
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Period544220Nifty 50Difference
1 week-9.1%-2.8% -6.3 pts
1 month-11.4%-6.8% -4.7 pts

Red flags

F-score 4 of 8
lookShare dilution Share count up 114% in a year
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Mar 2026
Sales ₹4 Cr +31.4% vs Mar 2024. Net profit ₹0 Cr -60.0%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Dr Lal Pathlabs Ltd32,73758.228.0 %
Vijaya Diagnostic Centre Ltd15,19281.020.5 %
Metropolis Healthcare Ltd11,66556.017.8 %
Thyrocare Technologies Ltd8,70848.235.4 %
Nephrocare Health Services Ltd6,67178.415.3 %
Suraksha Diagnostic Ltd1,84751.617.3 %
Krsnaa Diagnostics Ltd1,79118.112.7 %
3B Blackbio DX Ltd1,39625.125.5 %
One Global Service Provider Ltd1,04614.187.0 %
Health X Platform Ltd9230.03 %
Gaudium IVF and Women Health Ltd83035.929.3 %
Chandan Healthcare Ltd58122.123.3 %
Pramodini Medicare Ltd25914.941.8 %
Aspira Pathlab & Diagnostics Ltd1482.84 %
Choksi Laboratories Ltd13269.29.44 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Clinitech Laboratory Ltd?

Clinitech Laboratory Ltd (544220) has a market capitalisation of Rs 8.01 Cr. at the 2026-10-01 close.

What is the P/E ratio of Clinitech Laboratory Ltd?

Clinitech Laboratory Ltd trades at a P/E of 19.1 on trailing twelve-month profit, at the 2026-10-01 close.

What were Clinitech Laboratory Ltd's latest quarterly results?

In the Mar 2026 quarter, Clinitech Laboratory Ltd sales was Rs 4 Cr (+31.4% vs Mar 2024) and net profit was Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03